Blood test using artificial intelligence paves the way for early diagnosis of leprosy
A new blood test combined with a standardized questionnaire and artificial intelligence may transform leprosy diagnosis in Brazil. Researchers at the University of São Paulo tested the new test using blood samples collected during a COVID-19 population study.
Researchers at the University of São Paulo developed a new blood test combined with a standardized questionnaire and artificial intelligence to diagnose leprosy. The test was evaluated using blood samples collected during a COVID-19 population study in Brazil. This new diagnostic approach may transform the way leprosy is diagnosed in the country. The test's development is significant for early diagnosis and potentially improving treatment outcomes for leprosy patients.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.